Reported 1 day ago
AbbVie Inc. (ABBV) is among billionaire investor Ken Fisher's top healthcare stock picks, boasting a potential upside of 24.48%. The company focuses on novel treatments across various therapeutic areas and reported a strong fourth quarter in 2024, with a projected revenue of $59 billion for 2025. Despite challenges from regulatory reforms and market dynamics, AbbVie continues to expand through strategic acquisitions and a robust pipeline of clinical trials, making it a significant player poised for long-term growth.
Source: YAHOO